Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D001433:Bacteriolysis; D002939:Ciprofloxacin; D004731:Endotoxins / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009345:Neisseria meningitidis / Q000378:metabolism; D011112:Polymyxin B / Q000378:metabolism / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012772:Shock, Septic / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D011804:Quinolines; D002939:Ciprofloxacin; D011112:Polymyxin B